Evidence map›Paper›PMID 32182062›Full record

ArticleJournal of natural products2020

Kendomycin Cytotoxicity against Bacterial, Fungal, and Mammalian Cells Is Due to Cation Chelation.

Dale Tranter, Ireos Filipuzzi, Thomas Lochmann, Britta Knapp, Juho Kellosalo, David Estoppey, Dominik Pistorius, Axel Meissner, Ville O Paavilainen, Dominic Hoepfner

Open access · hybridAbstract read
In one paragraph

Article in Journal of natural products, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Genomic insights into an endophyticFrontiers in microbiology · 2024
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Dale TranterInstitute of Biotechnology, University of Helsinki, Helsinki, 00014, Finland.ORCID 0000-0001-7757-5484
Ireos FilipuzziNovartis Institutes for BioMedical Research, 4056 Basel, Switzerland.ORCID 0000-0002-2493-6183
Thomas LochmannNovartis Institutes for BioMedical Research, 4056 Basel, Switzerland.
Britta KnappNovartis Institutes for BioMedical Research, 4056 Basel, Switzerland.
Juho KellosaloInstitute of Biotechnology, University of Helsinki, Helsinki, 00014, Finland.
David EstoppeyNovartis Institutes for BioMedical Research, 4056 Basel, Switzerland.
Dominik PistoriusNovartis Institutes for BioMedical Research, 4056 Basel, Switzerland.
Axel MeissnerNovartis Institutes for BioMedical Research, 4056 Basel, Switzerland.
Ville O PaavilainenInstitute of Biotechnology, University of Helsinki, Helsinki, 00014, Finland.ORCID 0000-0002-3160-7767
Dominic HoepfnerNovartis Institutes for BioMedical Research, 4056 Basel, Switzerland.ORCID 0000-0001-8450-7543
Novartis (Switzerland) · CHUniversity of Helsinki · FI

Funding

Modulation of Protein Biogenesis and Secretion by Natural Product Translocon LigandsR01GM132649 · NIGMS · OREGON STATE UNIVERSITY · PI ISHMAEL, JANE E, MCPHAIL, KERRY LEIGH · 2019 to 2024
$2.0M
NIGMS NIH HHS R01 GM132649
6 · The paper itself

Abstract

Kendomycin is a small-molecule natural product that has gained significant attention due to reported cytotoxicity against pathogenic bacteria and fungi as well as a number of cancer cell lines. Despite significant biomedical interest and attempts to reveal its mechanism of action, the cellular target of kendomycin remains disputed. Herein it is shown that kendomycin induces cellular responses indicative of cation stress comparable to the effects of established iron chelators. Furthermore, addition of excess iron and copper attenuated kendomycin cytotoxicity in bacteria, yeast, and mammalian cells. Finally, NMR analysis demonstrated a direct interaction with cations, corroborating a close link between the observed kendomycin polypharmacology across different species and modulation of iron and/or copper levels.

Indexed as

Anti-Bacterial AgentsAntibiotics, AntineoplasticAntifungal AgentsBacteriaCationsCell LineChelating AgentsCopperFungiIronLeupeptinsMicrobial Sensitivity TestsMutagenesisRifabutinYeastsAnti-Bacterial AgentsAntibiotics, AntineoplasticAntifungal Agentsbenzyloxycarbonylleucyl-leucyl-leucine aldehydeCationsChelating AgentsCopperIronkendomycinLeupeptinsRifabutin

Identifiers

PMID32182062
PMCPMC7497661
OpenAlexW3012112168

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.